The TrkB signaling pathway overlaps with the ERK/MAPK or JAK2/STAT3 signaling pathway in myeloma or endometrial cancer cells [20,21], which prompted us to examine whether TrkB suppressed miR-204-5p expression via these signaling pathways. Here, NTRK2 is linked to endometrial cancer.